Agoracom: Small Cap Investment - Zenith Epigenetics - Re: BARCHART OPINION

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

coldnewfie

Rank: Treasurer [?]

Points: 561 [?]

Votes: 7 Score: 2.7 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: BARCHART OPINION - Overall Average 100% BUY

in response to

Re: BARCHART OPINION - Overall Average 100% BUY

jbuffett62

posted on Mar 08, 2023 04:10AM

When did they shut you down from buying .

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply